TUESDAY, Nov. 14, 2023 (HealthDay News) — Women who don’t get enough sleep might have an increased risk of diabetes, an effect even more pronounced in postmenopausal females, a new study finds. Shortening sleep by just 90 minutes increased insulin resistance in women used to getting adequate sleep, researchers atContinue Reading

WEDNESDAY, Nov. 8, 2023 (HealthDay News) — A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro. Both medications are madeContinue Reading